The NIH National Cancer Institute has released its annual "Cancer Trends Progress Report." 

The NIH National Cancer Institute has released its annual "Cancer Trends Progress Report." 

Four years ago, a study found that cancer has unique microbial signatures that would allow a blood test to diagnose cancer. But in recent months, the study has faced scrutiny for inaccurate data, The Wall Street Journal reported Aug. 30.

Asian American and Pacific Islander women once had relatively low rates of breast cancer, but the demographic is now seeing faster-rising rates of cancer compared to other races — and experts are not sure why, CBS News reported Sep. 3.

Houston-based Memorial Hermann Health System is expanding its partnership with on-demand cancer care company Reimagine Care.

The FDA approved afamitresgene autoleucel, or afami-cel (Tecelra), as the first T-cell receptor therapy for cancer.

Adding MRI to digital mammography may prevent more cancer deaths, but it also could contribute to false-positive biopsies, according to a study published Aug. 25 in JAMA Internal Medicine.

President Joe Biden launched the Cancer Moonshot in 2016, when he was serving as vice president in the Obama administration. President Biden reignited the initiative in 2022, setting a goal to reduce the cancer death rate by 50% in the next 25 years. 

Leaders from two top-five cancer centers, as ranked by U.S. News & World Report, shared with Becker's challenges they are facing this year and how they plan to address them.

Coral Gables-based Baptist Health South Florida has named Jenny Waltzer as COO of Baptist Health Cancer Care.

Jeffrey Weber, MD, PhD, a pioneer in cancer immunotherapy and melanoma research, recently died of cancer.

From landmark research investments to precision oncology networks, here are 10 recent oncology partnerships to know:

The University of Texas MD Anderson Cancer Center in Houston was awarded nine grants from the Cancer Prevention and Research Institute of Texas, totaling more than $21.4 million.

Sacramento, Calif.-based UC Davis Health expanded its same-day, in-home urgent care program to patients of UC Davis Comprehensive Cancer Center.

Penn Medicine's Abramson Cancer Center and the Parker Institute for Cancer Immunotherapy have renewed their partnership to advance cancer immunotherapy research.

The U.S. Preventive Services Task Force's lung cancer screening criteria may exclude people who could benefit from the screening, according to a study published Aug. 20 in Annals of Internal Medicine. 

Physicians are divided over two prostate cancer treatment protocols: the watch-and-wait approach and surgery.

Irvine, Calif.-based City of Hope Orange County named colorectal surgeon Alessio Pigazzi, MD, PhD, executive medical director of colorectal surgery and vice chair of clinical network affairs for the department of surgery.

In partnership with Microsoft, biotechnology company Paige has created the largest AI model for cancer diagnosis to date.

Hackensack Meridian Health's John Theurer Cancer Center in Hackensack, N.J., has launched a cancer risk assessment initiative, the goal of which is to improve access to screening and facilitate earlier detection.